News & Updates

Show Multimedia Only

Ceritinib shows therapeutic potential in ALK-positive nonsmall cell lung cancer

21 Jun 2022

The anaplastic lymphoma kinase (ALK) inhibitor ceritinib delivers favourable antitumour activity in ALK-mutated nonsmall cell lung cancer (NSCLC) patients with active brain metastases and/or leptomeningeal disease, according to the phase II ASCEND-7 trial.

Ceritinib shows therapeutic potential in ALK-positive nonsmall cell lung cancer

21 Jun 2022

Ramipril shows favourable effects in hypertensive kids on maintenance haemodialysis

21 Jun 2022

In hypertensive children undergoing maintenance haemodialysis, ramipril helps improve biomarkers of endothelial dysfunction and inflammation in addition to its blood pressure (BP)-lowering benefits, a study has found.

Ramipril shows favourable effects in hypertensive kids on maintenance haemodialysis

21 Jun 2022

Haemoglobin shares nonlinear correlation with bone mineral density

21 Jun 2022

There appears to be a significant but nonlinear association between haemoglobin levels and bone mineral density (BMD) at the lumbar and thoracic spine, a recent study has found.

Haemoglobin shares nonlinear correlation with bone mineral density

21 Jun 2022

Does your patient have headaches or migraines? Regardless, they can be managed successfully.

21 Jun 2022 by

While everyone has headaches at some point in their life, these episodes can turn severe and even chronic in some individuals. The pain can be debilitating to a point where one may find it difficult to do routine jobs.

Does your patient have headaches or migraines? Regardless, they can be managed successfully.

21 Jun 2022

Semaglutide reduces long-term T2D risk in overweight/obese patients

21 Jun 2022 by

Once-weekly injection of semaglutide significantly reduced the 10-year risk of developing type 2 diabetes (T2D) among overweight or obese patients, according to a post hoc analysis of the STEP* 1 and 4 trials presented at ADA 2022.

Semaglutide reduces long-term T2D risk in overweight/obese patients

21 Jun 2022

Oral peanut immunotherapy largely safe in kids, teens

20 Jun 2022

The peanut allergen powder-dnfp, a daily oral immunotherapy that helps avoid allergic reactions, has an acceptable safety profile in children and adolescents, a recent study has found. Most side effects are mild or moderate and wane over time.

Oral peanut immunotherapy largely safe in kids, teens

20 Jun 2022

Bimekizumab triumphs in bDMARD-naïve psoriatic arthritis patients

20 Jun 2022 by

Patients with psoriatic arthritis (PsA) with no prior exposure to biological disease-modifying antirheumatic drugs (bDMARDs) experience improvements in their condition when treated with bimekizumab, according to results of the phase III BE OPTIMAL trial.

Bimekizumab triumphs in bDMARD-naïve psoriatic arthritis patients

20 Jun 2022

Macular RNFL thickness flags future cognitive decline in older Asians

20 Jun 2022 by

Macular retinal nerve fibre layer (RNFL) thickness appears to be a useful prognostic biomarker of long-term cognitive decline in older adults, a study from Korea has found.

Macular RNFL thickness flags future cognitive decline in older Asians

20 Jun 2022

Insulin resistance tied to atherogenic lipoprotein/lipid, cIMT in obese youths

20 Jun 2022

Insulin resistance in young people with obesity is positively associated with an atherogenic lipoprotein/lipid profile and carotid intima-media thickness (cIMT), regardless of their glucose tolerance status, suggests a study.

Insulin resistance tied to atherogenic lipoprotein/lipid, cIMT in obese youths

20 Jun 2022

Intravenous push shortens time to initiation of antibiotics in ED

20 Jun 2022 by

Administration of ampicillin/sulbactam, piperacillin/tazobactam, and ertapenem via intravenous push (IVP) results in better times to initiation of empiric, first-dose antibiotics in the emergency department, (ED) without increasing the incidence of adverse events (AEs), a study has shown.

Intravenous push shortens time to initiation of antibiotics in ED

20 Jun 2022

News & Updates

Filter by Specialty:

Specialty:

Ceritinib shows therapeutic potential in ALK-positive nonsmall cell lung cancer

Ceritinib shows therapeutic potential in ALK-positive nonsmall cell lung cancer

Ramipril shows favourable effects in hypertensive kids on maintenance haemodialysis

Ramipril shows favourable effects in hypertensive kids on maintenance haemodialysis

Haemoglobin shares nonlinear correlation with bone mineral density

Haemoglobin shares nonlinear correlation with bone mineral density

Does your patient have headaches or migraines? Regardless, they can be managed successfully.

Does your patient have headaches or migraines? Regardless, they can be managed successfully.

Semaglutide reduces long-term T2D risk in overweight/obese patients

Semaglutide reduces long-term T2D risk in overweight/obese patients

Oral peanut immunotherapy largely safe in kids, teens

Oral peanut immunotherapy largely safe in kids, teens

Bimekizumab triumphs in bDMARD-naïve psoriatic arthritis patients

Bimekizumab triumphs in bDMARD-naïve psoriatic arthritis patients

Macular RNFL thickness flags future cognitive decline in older Asians

Macular RNFL thickness flags future cognitive decline in older Asians

Insulin resistance tied to atherogenic lipoprotein/lipid, cIMT in obese youths

Insulin resistance tied to atherogenic lipoprotein/lipid, cIMT in obese youths

Intravenous push shortens time to initiation of antibiotics in ED

Intravenous push shortens time to initiation of antibiotics in ED